Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids

Clinics

Volumn 64, Issue 4, 2009, Pages 313-318

  Yanik, Burcu ^a   Ayrim, Aylin ^a   Ozol, Duygu ^a   Koktener, Asli ^a   Gokmen, Derya ^b  

^a FATIH UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Asthma; Bone mineral densitometry; Inhaled steroids; Obesity; Osteoporosis

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID;

ARTICLE; ASTHMA; BODY MASS; BONE DENSITY; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; NONPARAMETRIC TEST; OBESITY; OSTEOPOROSIS; POSTMENOPAUSE; TIME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BODY MASS INDEX; BONE DENSITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MIDDLE AGED; OBESITY; OSTEOPOROSIS; POSTMENOPAUSE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 67650631834     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322009000400008     Document Type: Article

References (27)

1. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94:646-50.
2. Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, et al. Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res. 2008;23:17-29.
3. Soyka LA, Fairfield WP, Klibanski A. Clinical review 117: Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab. 2000;85:3951-63.
4. Dahl R. Systemic side effects of inhaled corticosteroids in patients with asthma. Respir Med. 2006;100:1307-17.
5. Egan JJ, Maden C, Kalra S, Adams JE, Eastell R, Woodcock AA. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J. 1999;13:1267-75.
6. Kaye TB. Effect of an inhaled glucocorticoid, flunisolide, on bone mineral density: a 2-year prospective, controlled trial. Endocr Pract. 2000;6:311-7.
7. McDonald CF, Zebaze RM, Seeman E. Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double- blind placebo-controlled trial. Osteoporos Int. 2006;17:1546-51.
8. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med. 2001;345:941-7.
9. Adams RJ, Wilson DH, Taylor AW, Daly A, Tursan d'Espaignet E, Dal Grande E et al. Coexistent chronic conditions and asthma quality of life: a population-based study. Chest. 2006;129:285-91.
10. Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR. Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med. 1999;159:1215-20.
11. www.ginasthma.com.
12. Clover E, Miller M, Bannerman E, Magarey A. Relative validation of a short food frequency questionnaire to assess calcium intake in older adults. Aust N Z J Public Health. 2007;31:450-8.
13. Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9:544-64.
14. Biskobing DM. COPD and osteoporosis. Chest. 2002;121:609-20.
15. Bourjeily G, Rochester CL Exercise training in chronic obstructive pulmonary disease. Clin Chest Med. 2000;21:763-81.
16. Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114:10-4.
17. Katsura H, Kida K. A comparison of bone mineral density in elderly female patients with COPD and bronchial asthma. Chest. 2002;122:1949-55.
18. Laatikainen AK, Kröger HP, Tukiainen HO, Honkanen RJ, Saarikoski SV. Bone mineral density in perimenopausal women with asthma: a population-based cross-sectional study. Am J Respir Crit Care Med. 1999;159:1179-85.
19. Appleton SL, Wilson DH, Tucker G, Ruffin RE, Taylor AW, Adams RJ, et al. Sex differences in asthma morbidity associated with obesity in a representative population sample. J Allergy Clin Immunol. 2008 May;121(5):1285-1287.e1.
20. Mazess RB, Barden HS, Drinka PJ, Bauwens SF, Orwoll ES, Bell NH. Influence of age and body weight on spine and femur bone mineral density in U.S. white men. J Bone Miner Res. 1990;5:645-52.
21. Baumgartner RN, Stauber PM, Koehler KM, Romero L, Garry PJ. Associations of fat and muscle masses with bone mineral in elderly men and women. Am J Clin Nutr. 1996;63:365-72.
22. Herrala j, Puolijoki H, Impivaara O, Liippo K, Tala E, Nieminen MM. Bone mineral density in asthmatic women on high-dose inhaled beclomethasone dipropionate. Bone. 1994;15:621-3.
23. Elmstahl S, Ekstrom H, Galvard H, Johnell O, Gerhardsson de Verdier M, et al. Is there an association between inhaled corticosteroids and bone density in postmenopausal women? J Allergy Clin Immunol. 2003;111:91-6.
24. Wong Ca, Walsh Lj, Smith Cj, Wisniewski AF, Lewis SA, Hubbard R, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet. 2000,22;355(9213):1399-403.
25. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol. 1995;96(5 Pt 1):571-9.
26. Fujita K, Kasayama S, Hashimoto J, Nagasaka Y, Nakano N, Morimoto Y, et al. Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women. J Bone Miner Res. 2001;16(4):782-7.
27. Tattersfield AE, Harrison TW, Hubbard RB, Mortimer K. Safety of inhaled corticosteroids. Proc Am Thorac Soc. 2004;1:171-5.